Evaluating the immunogenicity of protein drugs by applying in vitro MHC binding data and the immune epitope database and analysis resource

Clinical and Developmental Immunology

Volumn 2013, Issue , 2013, Pages

  Paul, Sinu ^a   Kolla, Ravi V ^a   Sidney, John ^a   Weiskopf, Daniela ^a   Fleri, Ward ^a   Kim, Yohan ^a   Peters, Bjoern ^a   Sette, Alessandro ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; DRUG; EPITOPE; ERYTHROPOIETIN; HLA ANTIGEN CLASS 2; POLLEN ANTIGEN; PROTEIN; HLA ANTIGEN;

AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; ARTIFICIAL NEURAL NETWORK; BINDING AFFINITY; DATA BASE; HIDDEN MARKOV MODEL; HUMAN; IMMUNOGENICITY; IN VITRO STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; REVIEW; IMMUNOLOGY; METABOLISM; PROTEIN BINDING; PROTEIN DATABASE;

DATABASES, PROTEIN; EPITOPES; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA ANTIGENS; HUMANS; PHARMACEUTICAL PREPARATIONS; PROTEIN BINDING; PROTEINS;

EID: 84886544432     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2013/467852     Document Type: Review

References (46)

1. Kropshofer H., Singer T., Overview of cell-based tools for pre-clinical assessment of immunogenicity of biotherapeutics. Journal of Immunotoxicology 2006 3 3 131 136 2-s2.0-33747628127 10.1080/15476910600845625 (Pubitemid 44266962)
2. Wolbink G. J., Aarden L. A., Dijkmans B. A. C., Dealing with immunogenicity of biologicals: assessment and clinical relevance. Current Opinion in Rheumatology 2009 21 3 211 215 2-s2.0-67650137185 10.1097/BOR.0b013e328329ed8b
3. Brinks V., Jiskoot W., Schellekens H., Immunogenicity of therapeutic proteins: the use of animal models. Pharmaceutical Research 2011 28 10 2379 2385 2-s2.0-80054738932 10.1007/s11095-011-0523-5
4. Guidance for industry: Immunogenicity assessment for therapeutic protein products. Food and Drug Administration, U.S. Department of Health and Human Services, 2013
5. Murphy K., Janeway's Immunobiology 2011 8th New York, NY, USA Garland Science
6. Paul W. E., Fundamental Immunology 2013 7th Philadelphia, Pa, USA Lippincott Williams & Wilkins
7. α immune response gene. Cell 1983 34 1 169 177 2-s2.0-0020608835 (Pubitemid 13045471)
8. Brown J. H., Jardetzky T. S., Gorga J. C., Stern L. J., Urban R. G., Strominger J. L., Wiley D. C., Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 1993 364 6432 33 39 2-s2.0-0027217789 10.1038/364033a0 (Pubitemid 23233452)
9. Greenbaum J., Sidney J., Chung J., Brander C., Peters B., Sette A., Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes. Immunogenetics 2011 63 6 325 335 2-s2.0-79958184746 10.1007/s00251-011-0513-0
10. McKinney D. M., Southwood S., Hinz D., Oseroff C., Arlehamn C. S. L., Schulten V., Taplitz R., Broide D., Hanekom W. A., Scriba T. J., A strategy to determine HLA class II restriction broadly covering the DR, DP, and DQ allelic variants most commonly expressed in the general population. Immunogenetics 2013 65 5 357 370 10.1007/s00251-013-0684-y
11. Nielsen M., Lundegaard C., Lund O., Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method. BMC Bioinformatics 2007 8, article 238 2-s2.0-34547778364 10.1186/1471-2105-8-238 (Pubitemid 47225391)
12. Sette A., Buus S., Appella E., Smith J. A., Chesnut R., Miles C., Colon S. M., Grey H. M., Prediction of major histocompatibility complex binding regions of protein antigens by sequence pattern analysis. Proceedings of the National Academy of Sciences of the United States of America 1989 86 9 3296 3300 2-s2.0-2942524864 (Pubitemid 19129598)
13. Brusic V., Rudy G., Honeyman G., Hammer J., Harrison L., Prediction of MHC class II-binding peptides using an evolutionary algorithm and artificial neural network. Bioinformatics 1998 14 2 121 130 2-s2.0-0031825709 (Pubitemid 28395870)
14. Tangri S., Mothé B. R., Eisenbraun J., Sidney J., Southwood S., Briggs K., Zinckgraf J., Bilsel P., Newman M., Chesnut R., LiCalsi C., Sette A., Rationally engineered therapeutic proteins with reduced immunogenicity. The Journal of Immunology 2005 174 6 3187 3196 2-s2.0-20144384746 (Pubitemid 40354020)
15. Kim Y., Ponomarenko J., Zhu Z., Immune epitope database analysis resource. Nucleic Acids Research 2008 40 W525 W530
16. Bristol J. A., Gallo-Penn A., Andrews J., Idamakanti N., Kaleko M., Connelly S., Adenovirus-mediated factor VIII gene expression results in attenuated anti-factor VIII-specific immunity in hemophilia A mice compared with factor VIII protein infusion. Human Gene Therapy 2001 12 13 1651 1661 2-s2.0-0034814009 10.1089/10430340152528147 (Pubitemid 32911735)
17. Kulkarni R., Aledort L. M., Berntorp E., Brackman H. H., Brown D., Cohen A. R., Ewing N. P., Gringeri A., Gruppo R., Hoots K., Leissenger C., Peerlinck K., Poon M. C., Wong W. Y., Therapeutic choices for patients with hemophilia and high-titer inhibitors. American Journal of Hematology 2001 67 4 240 246 10.1002/ajh.1192 (Pubitemid 32619310)
18. Reginster J. Y., Gaspar S., Deroisy R., Zegels B., Franchimont P., Prevention of osteoporosis with nasal salmon calcitonin: effect of anti-salmon calcitonin antibody formation. Osteoporosis International 1993 3 5 261 264 2-s2.0-0027185909 (Pubitemid 23252445)
19. Grauer A., Ziegler R., Raue F., Clinical significance of antibodies against calcitonin. Experimental and Clinical Endocrinology & Diabetes 1995 103 6 345 351 2-s2.0-0028853791
20. Casadevall N., Nataf J., Viron B., Kolta A., Kiladjian J.-J., Martin-Dupont P., Michaud P., Papo T., Ugo V., Teyssandier I., Varet B., Mayeux P., Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin. The New England Journal of Medicine 2002 346 7 469 475 2-s2.0-0037075272 10.1056/NEJMoa011931 (Pubitemid 34441737)
21. Gershon S. K., Luksenburg H., Coté T. R., Braun M. M., Sokol L., Prchal J. T., Casadevall N., Mayeux P., Bunn H. F., Pure red-cell aplasia and recombinant erythropoietin. The New England Journal of Medicine 2002 346 20 1584 1586 2-s2.0-0037118290 10.1056/NEJM200205163462015 (Pubitemid 34755702)
22. Deisenhammer F., Mayringer I., Harvey J., Dilitz E., Gasse T., Stadlbauer D., Reindl M., Berger T., A comparative study of the relative bioavailability of different interferon beta preparations. Neurology 2000 54 11 2055 2060 2-s2.0-0034643877 (Pubitemid 30397201)
23. Stern L. J., Brown J. H., Jardetzky T. S., Gorga J. C., Urban R. G., Strominger J. L., Wiley D. C., Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 1994 368 6468 215 221 2-s2.0-0028348369 10.1038/368215a0 (Pubitemid 24108837)
24. Rudensky A. Y., Preston-Hurlburt P., Hong S., Barlow A., Janeway C. A., Sequence analysis of peptides bound to MHC class II molecules. Nature 1991 353 6345 622 627 2-s2.0-0026042333 10.1038/353622a0 (Pubitemid 21912570)
25. Chicz R. M., Urban R. G., Lane W. S., Gorga J. C., Stern L. J., Vignali D. A. A., Strominger J. L., Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature 1992 358 6389 764 768 2-s2.0-0026733449 10.1038/358764a0
26. Castellino F., Zhong G., Germain R. N., Antigen presentation by MHC class II molecules: invariant chain function, protein trafficking, and the molecular basis of diverse determinant capture. Human Immunology 1997 54 2 159 169 2-s2.0-0030806054 10.1016/S0198-8859(97)00078-5 (Pubitemid 27381025)
27. Rammensee H., Friede T., Stevanović S., MHC ligands and peptide motifs: first listing. Immunogenetics 1995 41 4 178 228 2-s2.0-0028985984
28. Reche P. A., Glutting J.-P., Zhang H., Reinherz E. L., Enhancement to the RANKPEP resource for the prediction of peptide binding to MHC molecules using profiles. Immunogenetics 2004 56 6 405 419 2-s2.0-5444249860 10.1007/s00251-004-0709-7 (Pubitemid 39359226)
29. Rotzschke O., Falk K., Stevanovic S., Jung G., Walden P., Rammensee H. G., Exact prediction of a natural T cell epitope. European Journal of Immunology 1991 21 11 2891 2894 2-s2.0-0025944429
30. Bui H. H., Sidney J., Peters B., Sathiamurthy M., Sinichi A., Purton K.-A., Mothé B. R., Chisari F. V., Watkins D. I., Sette A., Automated generation and evaluation of specific MHC binding predictive tools: ARB matrix applications. Immunogenetics 2005 57 5 304 314 2-s2.0-21344466799 10.1007/s00251-005-0798-y (Pubitemid 40905049)
31. Nielsen M., Lund O., Buus S., Lundegaard C., MHC Class II epitope predictive algorithms. Immunology 2010 130 3 319 328 2-s2.0-77953520516 10.1111/j.1365-2567.2010.03268.x
32. Lundegaard C., Hoof I., Lund O., Nielsen M., State of the art and challenges in sequence based T-cell epitope prediction. Immunome Research 2010 6 supplement 2, article S3 2-s2.0-78149352601 10.1186/1745-7580-6-S2-S3
33. Wang P., Sidney J., Dow C., Mothé B., Sette A., Peters B., A systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach. PLoS Computational Biology 2008 4 4 2-s2.0-42949139524 10.1371/journal.pcbi.1000048 e1000048 (Pubitemid 351656722)
34. Lin H. H., Zhang G. L., Tongchusak S., Reinherz E. L., Brusic V., Evaluation of MHC-II peptide binding prediction servers: applications for vaccine research. BMC Bioinformatics 2008 9 supplement 12, article S22
35. Nielsen M., Lund O., NN-align, an artificial neural network-based alignment algorithm for MHC class II peptide binding prediction. BMC Bioinformatics 2009 10, article 296 2-s2.0-70449359806 10.1186/1471-2105-10-296
36. Nielsen M., Justesen S., Lund O., Lundegaard C., Buus S., NetMHCIIpan-2.0-improved pan-specific HLA-DR predictions using a novel concurrent alignment and weight optimization training procedure. Immunome Research 2010 6, article 9 2-s2.0-78149354807 10.1186/1745-7580-6-9
37. Salimi N., Fleri W., Peters B., Sette A., The immune epitope database: a historical retrospective of the first decade. Immunology 2012 137 2 117 123 10.1111/j.1365-2567.2012.03611.x
38. Wang P., Sidney J., Kim Y., Sette A., Lund O., Nielsen M., Peters B., Peptide binding predictions for HLA DR, DP and DQ molecules. BMC Bioinformatics 2010 11, article 568 2-s2.0-78549266517 10.1186/1471-2105-11-568
39. Sturniolo T., Bono E., Ding J., Raddrizzani L., Tuereci O., Sahin U., Braxenthaler M., Gallazzi F., Protti M. P., Sinigaglia F., Hammer J., Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices. Nature Biotechnology 1999 17 6 555 561 2-s2.0-0033021020 10.1038/9858 (Pubitemid 29262918)
40. Swets J. A., Measuring the accuracy of diagnostic systems. Science 1988 240 4857 1285 1293 2-s2.0-0023890867
41. Southwood S., Sidney J., Kondo A., Del Guercio M.-F., Appella E., Hoffman S., Kubo R. T., Chesnut R. W., Grey H. M., Sette A., Several common HLA-DR types share largely overlapping peptide binding repertoires. The Journal of Immunology 1998 160 7 3363 3373 2-s2.0-0032055915 (Pubitemid 28164729)
42. Oseroff C., Sidney J., Kotturi M. F., Kolla R., Alam R., Broide D. H., Wasserman S. I., Weiskopf D., McKinney D. M., Chung J. L., Petersen A., Grey H., Peters B., Sette A., Molecular determinants of T cell epitope recognition to the common timothy grass allergen. The Journal of Immunology 2010 185 2 943 955 2-s2.0-77955484239 10.4049/jimmunol.1000405
43. Oseroff C., Sidney J., Tripple V., Grey H., Wood R., Broide D. H., Greenbaum J., Kolla R., Peters B., Pomés A., Analysis of T cell responses to the major allergens from german cockroach: epitope specificity and relationship to IgE production. The Journal of Immunology 2012 189 2 679 688 10.4049/jimmunol.1200694
44. Oseroff C., Sidney J., Vita R., Tripple V., McKinney D. M., Southwood S., Brodie T. M., Sallusto F., Grey H., Alam R., T cell responses to known allergen proteins are differently polarized and account for a variable fraction of total response to allergen extracts. The Journal of Immunology 2012 189 4 1800 1811 10.4049/jimmunol.1200850
45. Schulten V., Greenbaum J. A., Hauser M., McKinney D. M., Sidney J., Kolla R., Arlehamn C. S. L., Oseroff C., Alam R., Broide D. H., Previously undescribed grass pollen antigens are the major inducers of T helper 2 cytokine-producing T cells in allergic individuals. Proceedings of the National Academy of Sciences 2013 110 9 3459 3464 10.1073/pnas.1300512110
46. + Th1 subset. PLoS Pathogens 2013 9 1 e1003130 10.1371/journal.ppat.1003130